Veradermics MANE
NYSE MANE
$116.74 -0.51 (-0.43%)
At close: Oct 2, 2026 · 4:00 PM EDT

Veradermics (MANE) Change in Accured Expenses (2025 - 2026)

Updated

Veradermics (MANE) posted Change in Accured Expenses of -$211,000 for Q2 2026, compared with $1.56 million a year earlier.

Analysis

Veradermics (MANE) Change in Accured Expenses (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Veradermics was -$882,000; for FY2025, it was $4.51 million, up 254.8% from FY2024.

  • In prior years, Veradermics' Change in Accured Expenses was $1.27 million in FY2024.
  • Quarterly Change in Accured Expenses has run from a low of -$1.37 million in Q1 2026 to a high of $1.56 million in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Veradermics 4.88 Bn 4.88 Bn - -211,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -211,000.00
Mar 31, 2026 -1.37 Mn
Jun 30, 2025 1.56 Mn
Mar 31, 2025 -862,000.00
API Access

Veradermics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=MANE&period=max&api_key=YOUR_API_KEY